InvestorsHub Logo
icon url

Delsurfer

08/16/17 10:03 AM

#53486 RE: Alyssa #53477

Not intending to start a debate here. Just stating my opinions.

1. All paid promotions are suspect in my opinion. Have you ever seen one that wasn't positive?

2. When this piece was written there were 30mm shares outstanding, not 1 billion.

3. Much of the value that they placed on the stock was predicated on OvaDX approval - OvaDX is no where near FDA submission. Technically Arrayit doesn't even own the IP anymore - Avant does.

4. There is a lot that COULD happen but I don't see the company doubling or tripling sales any time soon (basing this on an expected $6-$10mm revenue figure for 2016/2017). By the company's own admission, their growth mirrors Illumina's which was in the 10% range.
icon url

Full Contact Yoga

08/16/17 11:49 AM

#53493 RE: Alyssa #53477

Yet, they've defaulted on virtually every debt, have lost multiple lawsuits, have failed to pay said lawsuits although ordered by the court to do so, are in constant litigation, and have failed to file anything of value since 2013...the only verifiable thing they've done is failed to issue shares and settlements as ordered by the court, and, have failed to file anything to stave off the massive amount of shares required to satisfy some of the defaulted debt, as a side note, anything of value secures the debt, so, they really own nothing but problems and debt...and, of course, they raised the AS by 2,000,000,000, which, is earmarked for some of debt should filings ever hit I imagine...